Highlands Oncology


Highlands Oncology is a leading cancer center in northwest Arkansas, providing care to over 12,000 patients from many different states in the region. They have been participating in clinical trials for over 20 years, and their Research Department runs numerous trials in both oncology and hematology. These trials are designed to compare new experimental medications and treatments to existing options in order to advance cancer care for patients around the world. Highlands Oncology is also the only community-based Phase I oncology clinical trial center in the state of Arkansas. With help from their Research Department and clinical trials, they stay at the cutting edge of technology, ensuring they can offer the latest treatments and improved outcomes to their patients. They are committed to advancing cancer care and hope to continue to be a leader in the field. With multidisciplinary cancer teams, highly advanced treatment options, and industry leading clinical studies, Highlands Oncology Group offers nationally recognized cancer care right here in northwest Arkansas.

Impeccable success in conducting clinical trials can be attributed to the following, and more.

  • Robust research department comprised of over 30 research specialists
  • Three cancer centers, each equipped with consenting, imaging, and pharmacy capabilities
  • Major research center at Springdale location
  • Integration with primary clinical staff, such as universal pre-screening for clinical trial inclusion
  • Host site for multiple multidisciplinary tumor boards, enhancing opportunities for patient identification and subsequent enrollment from a wider network
  • Only community based Phase I oncology clinical trial center in the state of Arkansas

Quick Facts

  • 49.9% Female (50.92% Arkansas)
  • 62.45% White, 17.89% Hispanic/Latino (77.31% White, 7.16% Hispanic/Latino Arkansas)
  • 13% uninsured (10.64% Arkansas)

Health Outcomes

  • Cancer is the second leading cause of death in Arkansas
  • Arkansas amongst five states with the highest age-adjusted lung cancer death rates per 100,000

Highlands Oncology is a premier destination for clinical research, offering the following:

  • Highly trained dedicated research department, with ICH/GCP and human subject protection training certifications
  • EMR-integrated and AI-driven research tools for patient screening
  • Timely tissue biopsy processing, due to partnership with local hospitals and pathology associates
  • Dedicated clinical research pharmacist
  • Remote and on-site monitoring capabilities
  • In-house support for research budgets and contracts
  • Standardized lab ranges at all three locations, with capacity to send out to LabCorp or Northwest Arkansas
  • Pathology Associates for additional research
  • Central and local IRB facilitation, with central preferred
  • Dedicated primary Research Data Coordinator assigned to each study

Some of the Hospital’s Amenities:

  • Total of 67 exam rooms, 6 procedure rooms, 106 treatment chairs, and 4 shot chairs among three locations
    • Two exam rooms reserved for research subjects


  • 10 on-site monitoring stations with computer, printer, copier, scanner, a phone, and Wi-Fi
  • Software licenses include: Ambra, Deep Lens, Florence, DocuSign, OncoEMR, OncoTrials, Velos, and Vestigo

Research Staff

Helen Holtzen
MS, RN, Director of Research Bio
Adam Torres
BSBA, BSN, RN, CCRP, Assistant Director of Research Bio